• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CARLSBAD 数据库:一个化学生物活性的联合数据库。

The CARLSBAD database: a confederated database of chemical bioactivities.

机构信息

Department of Internal Medicine, Translational Informatics Division, University of New Mexico School of Medicine, 1 University of New Mexico, MSC09 5025, Albuquerque, NM 87131, USA.

出版信息

Database (Oxford). 2013 Jun 21;2013:bat044. doi: 10.1093/database/bat044. Print 2013.

DOI:10.1093/database/bat044
PMID:23794735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3689437/
Abstract

Many bioactivity databases offer information regarding the biological activity of small molecules on protein targets. Information in these databases is often hard to resolve with certainty because of subsetting different data in a variety of formats; use of different bioactivity metrics; use of different identifiers for chemicals and proteins; and having to access different query interfaces, respectively. Given the multitude of data sources, interfaces and standards, it is challenging to gather relevant facts and make appropriate connections and decisions regarding chemical-protein associations. The CARLSBAD database has been developed as an integrated resource, focused on high-quality subsets from several bioactivity databases, which are aggregated and presented in a uniform manner, suitable for the study of the relationships between small molecules and targets. In contrast to data collection resources, CARLSBAD provides a single normalized activity value of a given type for each unique chemical-protein target pair. Two types of scaffold perception methods have been implemented and are available for datamining: HierS (hierarchical scaffolds) and MCES (maximum common edge subgraph). The 2012 release of CARLSBAD contains 439 985 unique chemical structures, mapped onto 1,420 889 unique bioactivities, and annotated with 277 140 HierS scaffolds and 54 135 MCES chemical patterns, respectively. Of the 890 323 unique structure-target pairs curated in CARLSBAD, 13.95% are aggregated from multiple structure-target values: 94 975 are aggregated from two bioactivities, 14 544 from three, 7 930 from four and 2214 have five bioactivities, respectively. CARLSBAD captures bioactivities and tags for 1435 unique chemical structures of active pharmaceutical ingredients (i.e. 'drugs'). CARLSBAD processing resulted in a net 17.3% data reduction for chemicals, 34.3% reduction for bioactivities, 23% reduction for HierS and 25% reduction for MCES, respectively. The CARLSBAD database supports a knowledge mining system that provides non-specialists with novel integrative ways of exploring chemical biology space to facilitate knowledge mining in drug discovery and repurposing. Database URL: http://carlsbad.health.unm.edu/carlsbad/.

摘要

许多生物活性数据库提供有关小分子对蛋白质靶标的生物活性的信息。这些数据库中的信息由于在各种格式中细分不同的数据、使用不同的生物活性指标、对化学品和蛋白质使用不同的标识符以及分别访问不同的查询界面,因此很难确定。鉴于众多的数据源、接口和标准,收集与化学-蛋白质关联相关的事实并做出适当的关联和决策具有挑战性。CARLSBAD 数据库是作为一个集成资源开发的,重点是来自几个生物活性数据库的高质量子集,这些子集以统一的方式聚合和呈现,适合于研究小分子和靶标之间的关系。与数据收集资源不同,CARLSBAD 为每个独特的化学-蛋白质靶标对提供给定类型的单个归一化活性值。已经实现了两种类型的支架感知方法,可用于数据挖掘:HierS(层次支架)和 MCES(最大公共边缘子图)。CARLSBAD 的 2012 版本包含 439985 个独特的化学结构,映射到 1420889 个独特的生物活性上,分别注释有 277140 个 HierS 支架和 54135 个 MCES 化学模式。在 CARLSBAD 中 curated 的 890323 个独特的结构-靶标对中,有 13.95%是从多个结构-靶标值聚合而来的:94975 个是从两种生物活性聚合而来的,14544 个是从三种生物活性聚合而来的,7930 个是从四种生物活性聚合而来的,2214 个有五种生物活性。CARLSBAD 捕获了 1435 种活性药物成分(即“药物”)的独特化学结构的生物活性和标签。CARLSBAD 处理导致化学品数据减少 17.3%,生物活性减少 34.3%,HierS 减少 23%,MCES 减少 25%。CARLSBAD 数据库支持知识挖掘系统,为非专业人士提供了探索化学生物学空间的新的综合方法,有助于促进药物发现和再利用中的知识挖掘。数据库网址:http://carlsbad.health.unm.edu/carlsbad/。

相似文献

1
The CARLSBAD database: a confederated database of chemical bioactivities.CARLSBAD 数据库:一个化学生物活性的联合数据库。
Database (Oxford). 2013 Jun 21;2013:bat044. doi: 10.1093/database/bat044. Print 2013.
2
FerroLigandDB: A Ferroptosis Ligand Database of Structure-Activity Relations.FerroLigandDB:一个铁死亡配体数据库,包含结构-活性关系。
J Chem Inf Model. 2024 Jul 8;64(13):5052-5062. doi: 10.1021/acs.jcim.4c00525. Epub 2024 Jun 17.
3
TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.TargetHunter:一种基于化学生物基因组数据库的计算机辅助药物靶点预测工具,用于预测小分子药物的治疗潜力。
AAPS J. 2013 Apr;15(2):395-406. doi: 10.1208/s12248-012-9449-z. Epub 2013 Jan 5.
4
Fundamental Bioinformatic and Chemoinformatic Data Processing.基础生物信息学和化学信息学数据处理
Methods Mol Biol. 2018;1825:95-129. doi: 10.1007/978-1-4939-8639-2_3.
5
NALDB: nucleic acid ligand database for small molecules targeting nucleic acid.NALDB:用于小分子靶向核酸的核酸配体数据库。
Database (Oxford). 2016 Feb 20;2016. doi: 10.1093/database/baw002. Print 2016.
6
STITCH: interaction networks of chemicals and proteins.STITCH:化学物质与蛋白质的相互作用网络。
Nucleic Acids Res. 2008 Jan;36(Database issue):D684-8. doi: 10.1093/nar/gkm795. Epub 2007 Dec 15.
7
Chemotext: A Publicly Available Web Server for Mining Drug-Target-Disease Relationships in PubMed.化文:一个可公开获取的用于从 PubMed 中挖掘药物-靶标-疾病关系的网络服务器。
J Chem Inf Model. 2018 Feb 26;58(2):212-218. doi: 10.1021/acs.jcim.7b00589. Epub 2018 Jan 19.
8
SwissBioisostere: a database of molecular replacements for ligand design.瑞士生物等排体:用于配体设计的分子替换数据库。
Nucleic Acids Res. 2013 Jan;41(Database issue):D1137-43. doi: 10.1093/nar/gks1059. Epub 2012 Nov 17.
9
ReactionMap: an efficient atom-mapping algorithm for chemical reactions.反应映射:化学反应的高效原子映射算法。
J Chem Inf Model. 2013 Nov 25;53(11):2812-9. doi: 10.1021/ci400326p. Epub 2013 Nov 11.
10
DTome: a web-based tool for drug-target interactome construction.DTome:一个用于药物-靶标相互作用组构建的网络工具。
BMC Bioinformatics. 2012 Jun 11;13 Suppl 9(Suppl 9):S7. doi: 10.1186/1471-2105-13-S9-S7.

引用本文的文献

1
Recent advances in anti-inflammatory active components and action mechanisms of natural medicines.天然药物抗炎活性成分及作用机制的最新研究进展。
Inflammopharmacology. 2023 Dec;31(6):2901-2937. doi: 10.1007/s10787-023-01369-9. Epub 2023 Nov 10.
2
Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy.从人多能干细胞中诱导出雪旺细胞,可用于糖尿病周围神经病变的疾病建模和药物发现。
Cell Stem Cell. 2023 May 4;30(5):632-647.e10. doi: 10.1016/j.stem.2023.04.006.
3
Knowledge graph analytics platform with LINCS and IDG for Parkinson's disease target illumination.

本文引用的文献

1
Symmetric kv1.5 blockers discovered by focused screening.通过聚焦筛选发现的对称型钾通道蛋白1.5阻滞剂。
ACS Med Chem Lett. 2012 Aug 16;3(9):769-73. doi: 10.1021/ml3001787. eCollection 2012 Sep 13.
2
Estimating error rates in bioactivity databases.估算生物活性数据库中的错误率。
J Chem Inf Model. 2013 Oct 28;53(10):2499-505. doi: 10.1021/ci400099q. Epub 2013 Oct 2.
3
A chemogenomic analysis of ionization constants--implications for drug discovery.化学生物基因组学分析——对药物发现的启示。
具有 LINCS 和 IDG 的知识图谱分析平台,用于帕金森病靶点照明。
BMC Bioinformatics. 2022 Jan 12;23(1):37. doi: 10.1186/s12859-021-04530-9.
4
Towards reproducible computational drug discovery.迈向可重复的计算药物发现。
J Cheminform. 2020 Jan 28;12(1):9. doi: 10.1186/s13321-020-0408-x.
5
A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.促进网络药理学驱动的COVID-19研究的综合资源工作流程。
bioRxiv. 2020 Nov 5:2020.11.04.369041. doi: 10.1101/2020.11.04.369041.
6
Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.通过大数据和数据驱动的机器学习建模来推动计算机辅助药物发现 (CADD)。
Drug Discov Today. 2020 Sep;25(9):1624-1638. doi: 10.1016/j.drudis.2020.07.005. Epub 2020 Jul 11.
7
CMTTdb: the cancer molecular targeted therapy database.CMTTdb:癌症分子靶向治疗数据库。
Ann Transl Med. 2019 Nov;7(22):667. doi: 10.21037/atm.2019.10.23.
8
Toxicology Data Resources to Support Read-Across and (Q)SAR.支持类推和(定量)构效关系的毒理学数据资源。
Front Pharmacol. 2019 Jun 11;10:561. doi: 10.3389/fphar.2019.00561. eCollection 2019.
9
Probing the chemical-biological relationship space with the Drug Target Explorer.使用药物靶点探索器探究化学-生物学关系空间。
J Cheminform. 2018 Aug 20;10(1):41. doi: 10.1186/s13321-018-0297-4.
10
VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization.VB-MK-LMF:使用变分贝叶斯多核逻辑矩阵分解融合药物、靶点及相互作用
BMC Bioinformatics. 2017 Oct 4;18(1):440. doi: 10.1186/s12859-017-1845-z.
ChemMedChem. 2013 Feb;8(2):242-55. doi: 10.1002/cmdc.201200507. Epub 2013 Jan 9.
4
ChemProt-2.0: visual navigation in a disease chemical biology database.ChemProt-2.0:疾病化学生物学数据库中的可视化导航。
Nucleic Acids Res. 2013 Jan;41(Database issue):D464-9. doi: 10.1093/nar/gks1166. Epub 2012 Nov 26.
5
IUPHAR-DB: updated database content and new features.IUPHAR-DB:更新数据库内容和新功能。
Nucleic Acids Res. 2013 Jan;41(Database issue):D1083-8. doi: 10.1093/nar/gks960. Epub 2012 Oct 18.
6
Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer-Aided Drug Repurposing.将药物、靶点和临床结果关联到一个整合网络中,为计算机辅助药物重新利用提供了一个新平台。
Mol Inform. 2011 Mar 14;30(2-3):100-111. doi: 10.1002/minf.201100023.
7
Analysis of commercial and public bioactivity databases.商业和公共生物活性数据库分析。
J Chem Inf Model. 2012 Feb 27;52(2):319-26. doi: 10.1021/ci2003126. Epub 2011 Dec 6.
8
Reorganizing the protein space at the Universal Protein Resource (UniProt).重新组织通用蛋白质资源库(UniProt)中的蛋白质空间。
Nucleic Acids Res. 2012 Jan;40(Database issue):D71-5. doi: 10.1093/nar/gkr981. Epub 2011 Nov 18.
9
ChEMBL: a large-scale bioactivity database for drug discovery.ChEMBL:用于药物发现的大型生物活性数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7. doi: 10.1093/nar/gkr777. Epub 2011 Sep 23.
10
MultiMCS: a fast algorithm for the maximum common substructure problem on multiple molecules.MultiMCS:一种用于多个分子最大公共子结构问题的快速算法。
J Chem Inf Model. 2011 Apr 25;51(4):788-806. doi: 10.1021/ci100297y. Epub 2011 Mar 29.